Author
1. Sehgal Virendra N
ISBN
9789351527954
DOI
10.5005/jp/books/12893_7
Edition
4/e
Publishing Year
2017
Pages
8
Author Affiliations
1.
Skin Institute and School of Dermatology, Greater Kailash, New Delhi, India,
University College of Medical Sciences and
Associated Guru Teg Bahadur Hospital
Delhi,
Dermato-Venereology Skin/VD Centre, Sehgal Nursing Home, A-6 Panchwati Delhi, India,
Maulana Azad Medical College and Associated, Lok Nayak Jay Prakash Hospital, New Delhi, India,
Skin/VD Center, Sehgal Nursing Home, Delhi, India; Skin Institute and School of Dermatology, New Delhi, India,
Sehgal Nursing Home, Dermato-Venereology (Skin/VD) Centre, A/6, Panchwati, Azadpur, New Delhi, India,
Sehgal Nursing Home, Dermatovenereology (Skin/VD) Center, Azadpur, New Delhi, India,
Lady Hardinge Medical College and Sucheta Kriplani Hospital, New Delhi; New Delhi, India
Chapter keywords
adalimumab,
alefacept,
amevive,
biologics,
certolizumab,
efalizumab,
etanercept,
golimumab,
humira,
infliximab,
iological agents,
omalizumab,
rituximab,
therapeutic applications,
therapeutic applications,
tumor necrosis,
ustekinumab